English

ONCOVISTA INNOVATIVE THERAPIES, INC

EDGAR

Quarterly report (10-Q) · filed 2015-11-12

74 filing records in this dataset, filed from 2001-03-27 to 2015-11-12. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Cash and cash equivalents: 2.46 million USD 2011-09-30 Source
Exact value

2461847 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Operating cash flow

-1.52 million USD

2006-10-01 – 2007-09-30

Exact inputs and evidence

Operating cash flow: -245493 USD · 2006-01-01 – 2006-12-31 Source
Operating cash flow: -199047 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: 249 USD · 2007-01-01 – 2007-03-31 Source
Operating cash flow: 63157 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: 249 USD · 2007-01-01 – 2007-03-31 Source
Operating cash flow: -1468732 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: 63157 USD · 2007-01-01 – 2007-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-11-12.

Financial data available through: 2010-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2010-12-31
Operating income: 11 of 11 periods available· newest 2010-12-31
Net income: 11 of 11 periods available· newest 2010-12-31
Operating cash flow: 7 of 11 periods available· newest 2006-12-31
Capital expenditure: 2 of 11 periods available· newest 2006-12-31
Total assets: 10 of 11 periods available· newest 2010-12-31
Total liabilities: 5 of 11 periods available· newest 2009-12-31
Current assets: 11 of 11 periods available· newest 2010-12-31
Current liabilities: 11 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2009-01-01 – 2009-12-31
Current period

USD 0

2010-01-01 – 2010-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
0 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ONCOVISTA INNOVATIVE THERAPIES, INC · 2010-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-11-018509.txt#7608 Input fundies:Revenue: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-11-018509.txt#7608
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 14.89 million

Prior period

−USD 4.78 million

2009-01-01 – 2009-12-31
Current period

USD 10.1 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

10103400 − -4783000 = 14886400 USD

-4783000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
10103400 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ONCOVISTA INNOVATIVE THERAPIES, INC · 2010-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Year-over-year change in Net income: 14886400 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 10103400 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-11-018509.txt#8066 Input fundies:NetIncome: -4783000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-11-018509.txt#8066
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 0
Operating costs Derived USD 2.4 million
Operating income −USD 2.4 million
Tax, interest and other Derived −USD 12.5 million
Net income USD 10.1 million

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Not shown: operating income or net income is not reported.
2002 Not shown: operating income or net income is not reported.
2003 Not shown: operating income or net income is not reported.
2004 Operating loss: operating costs were 641% of revenue.
2005 Operating loss: operating costs were 306% of revenue.
2006 Operating loss: operating costs were 291% of revenue.
2007 Operating loss: operating costs were 380% of revenue.
2008 Operating loss: operating costs were 1,692% of revenue.
2009 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2001-01-01 – 2001-12-31	0	386025 Derived	-386025	-3806 Derived	-382219	Unavailable	Source 2001-01-01 – 2001-12-31: 0 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -386025 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -382219 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -310280 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	0	699565 Derived	-699565	6489 Derived	-706054	Unavailable	Source 2002-01-01 – 2002-12-31: 0 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -699565 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -706054 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -133621 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	0	371222 Derived	-371222	16207 Derived	-387429	Unavailable	Source 2003-01-01 – 2003-12-31: 0 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -371222 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -387429 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -179257 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	77994	499666 Derived	-421672	21927 Derived	-443599	Unavailable	Source 2004-01-01 – 2004-12-31: 77994 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -421672 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -443599 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -164050 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	148271	453153 Derived	-304882	-31208 Derived	-273674	-116714 Derived	Source 2005-01-01 – 2005-12-31: 148271 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -304882 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -273674 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -116714 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 0 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	1927456	5611209 Derived	-3683753	4984469 Derived	-8668222	-245493 Derived	Source 2006-01-01 – 2006-12-31: 1927456 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -3683753 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -8668222 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -245493 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 0 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	1967990	7486202 Derived	-5518212	84181 Derived	-5602393	Unavailable	Source 2007-01-01 – 2007-12-31: 1967990 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -5518212 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -5602393 USD Inspect Net Income Open source
2008 2008-01-01 – 2008-12-31	503325	8514746 Derived	-8011421	-529397 Derived	-7482024	Unavailable	Source 2008-01-01 – 2008-12-31: 503325 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -8011421 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -7482024 USD Inspect Net Income Open source
2009 2009-01-01 – 2009-12-31	0	3927904 Derived	-3927904	855096 Derived	-4783000	Unavailable	Source 2009-01-01 – 2009-12-31: 0 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -3927904 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -4783000 USD Inspect Net Income Open source
2010 2010-01-01 – 2010-12-31	0	2398481 Derived	-2398481	-12501881 Derived	10103400	Unavailable	Source 2010-01-01 – 2010-12-31: 0 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -2398481 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 10103400 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Revenue	0	Revenue: 0 Open source
20022002-12-31	Revenue	0	Revenue: 0 Open source
20032003-12-31	Revenue	0	Revenue: 0 Open source
20042004-12-31	Revenue	77994	Revenue: 77994 Open source
20052005-12-31	Revenue	148271	Revenue: 148271 Open source
20062006-12-31	Revenue	1927456	Revenue: 1927456 Open source
20072007-12-31	Revenue	1967990	Revenue: 1967990 Open source
20082008-12-31	Revenue	503325	Revenue: 503325 Open source
20092009-12-31	Revenue	0	Revenue: 0 Open source
20102010-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2009

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20022002-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20032003-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20042004-12-31	Year over year	No prior comparable period	Revenue: 77994 Open source Revenue: 0 Open source
20052005-12-31	Year over year	90.1%	Revenue: 148271 Open source Revenue: 77994 Open source
20062006-12-31	Year over year	1,200%	Revenue: 1927456 Open source Revenue: 148271 Open source
20072007-12-31	Year over year	2.1%	Revenue: 1967990 Open source Revenue: 1927456 Open source
20082008-12-31	Year over year	-74.4%	Revenue: 503325 Open source Revenue: 1967990 Open source
20092009-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 503325 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,591.7% 2008

Net margin -1,486.5% 2008

Free cash flow margin -12.7% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Operating margin	Not reported	Operating Income: -386025 Open source Revenue: 0 Open source
20022002-12-31	Operating margin	Not reported	Operating Income: -699565 Open source Revenue: 0 Open source
20032003-12-31	Operating margin	Not reported	Operating Income: -371222 Open source Revenue: 0 Open source
20042004-12-31	Operating margin	-540.6%	Operating Income: -421672 Open source Revenue: 77994 Open source
20052005-12-31	Operating margin	-205.6%	Operating Income: -304882 Open source Revenue: 148271 Open source
20062006-12-31	Operating margin	-191.1%	Operating Income: -3683753 Open source Revenue: 1927456 Open source
20072007-12-31	Operating margin	-280.4%	Operating Income: -5518212 Open source Revenue: 1967990 Open source
20082008-12-31	Operating margin	-1,591.7%	Operating Income: -8011421 Open source Revenue: 503325 Open source
20092009-12-31	Operating margin	Not reported	Operating Income: -3927904 Open source Revenue: 0 Open source
20102010-12-31	Operating margin	Not reported	Operating Income: -2398481 Open source Revenue: 0 Open source
20012001-12-31	Net margin	Not reported	Net Income: -382219 Open source Revenue: 0 Open source
20022002-12-31	Net margin	Not reported	Net Income: -706054 Open source Revenue: 0 Open source
20032003-12-31	Net margin	Not reported	Net Income: -387429 Open source Revenue: 0 Open source
20042004-12-31	Net margin	-568.8%	Net Income: -443599 Open source Revenue: 77994 Open source
20052005-12-31	Net margin	-184.6%	Net Income: -273674 Open source Revenue: 148271 Open source
20062006-12-31	Net margin	-449.7%	Net Income: -8668222 Open source Revenue: 1927456 Open source
20072007-12-31	Net margin	-284.7%	Net Income: -5602393 Open source Revenue: 1967990 Open source
20082008-12-31	Net margin	-1,486.5%	Net Income: -7482024 Open source Revenue: 503325 Open source
20092009-12-31	Net margin	Not reported	Net Income: -4783000 Open source Revenue: 0 Open source
20102010-12-31	Net margin	Not reported	Net Income: 10103400 Open source Revenue: 0 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -310280 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -133621 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -179257 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 77994 Open source Operating Cash Flow: -164050 Open source
20052005-12-31	Free cash flow margin	-78.7%	Revenue: 148271 Open source Operating Cash Flow: -116714 Open source Capital Expenditure: 0 Open source
20062006-12-31	Free cash flow margin	-12.7%	Revenue: 1927456 Open source Operating Cash Flow: -245493 Open source Capital Expenditure: 0 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 1967990 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 503325 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -245.5K 2006

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Operating cash flow	-310280	Operating Cash Flow: -310280 Open source
20022002-12-31	Operating cash flow	-133621	Operating Cash Flow: -133621 Open source
20032003-12-31	Operating cash flow	-179257	Operating Cash Flow: -179257 Open source
20042004-12-31	Operating cash flow	-164050	Operating Cash Flow: -164050 Open source
20052005-12-31	Operating cash flow	-116714	Operating Cash Flow: -116714 Open source
20062006-12-31	Operating cash flow	-245493	Operating Cash Flow: -245493 Open source
20072007-12-31	Operating cash flow	Not reported	No source recorded
20082008-12-31	Operating cash flow	Not reported	No source recorded
20092009-12-31	Operating cash flow	Not reported	No source recorded
20102010-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -245.5K 2006

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: -310280 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: -133621 Open source
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: -179257 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -164050 Open source
20052005-12-31	Free cash flow	-116714	Operating Cash Flow: -116714 Open source Capital Expenditure: 0 Open source
20062006-12-31	Free cash flow	-245493	Operating Cash Flow: -245493 Open source Capital Expenditure: 0 Open source
20072007-12-31	Free cash flow	Unavailable	No source recorded
20082008-12-31	Free cash flow	Unavailable	No source recorded
20092009-12-31	Free cash flow	Unavailable	No source recorded
20102010-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

2,842.6% 2009

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Liabilities / assets	Not reported	Total Assets: 18697 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 1692 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 58624 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 58670 Open source
20052005-12-31	Liabilities / assets	2,108.5%	Total Liabilities: 1652406 Open source Total Assets: 78370 Open source
20062006-12-31	Liabilities / assets	335.2%	Total Liabilities: 7935434 Open source Total Assets: 2367146 Open source
20072007-12-31	Liabilities / assets	180.7%	Total Liabilities: 8942282 Open source Total Assets: 4949949 Open source
20082008-12-31	Liabilities / assets	1,606.1%	Total Liabilities: 8899912 Open source Total Assets: 554133 Open source
20092009-12-31	Liabilities / assets	2,842.6%	Total Liabilities: 11658647 Open source Total Assets: 410142 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 3550154 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.86× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Current assets / current liabilities	0.23×	Current Assets: 18347 Open source Current Liabilities: 80420 Open source
20022002-12-31	Current assets / current liabilities	0×	Current Assets: 1342 Open source Current Liabilities: 705488 Open source
20032003-12-31	Current assets / current liabilities	0.02×	Current Assets: 18274 Open source Current Liabilities: 1070934 Open source
20042004-12-31	Current assets / current liabilities	0.01×	Current Assets: 14992 Open source Current Liabilities: 1359032 Open source
20052005-12-31	Current assets / current liabilities	0.03×	Current Assets: 52023 Open source Current Liabilities: 1652406 Open source
20062006-12-31	Current assets / current liabilities	0.77×	Current Assets: 2085126 Open source Current Liabilities: 2699083 Open source
20072007-12-31	Current assets / current liabilities	0.96×	Current Assets: 4694226 Open source Current Liabilities: 4902311 Open source
20082008-12-31	Current assets / current liabilities	0.07×	Current Assets: 348683 Open source Current Liabilities: 5033110 Open source
20092009-12-31	Current assets / current liabilities	0.02×	Current Assets: 274472 Open source Current Liabilities: 11658647 Open source
20102010-12-31	Current assets / current liabilities	1.86×	Current Assets: 3531875 Open source Current Liabilities: 1893830 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 382,219 Exact value Exact value: -382219 USD 2001-01-01 – 2001-12-31: -382219 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOVISTA INNOVATIVE THERAPIES, INC · 2001-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Net Income: -382219 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -382219 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001259988-04-000042.txt#967 The citation records this snapshot. The page link may show a newer release later.	−USD 310,280 Exact value Exact value: -310280 USD 2001-01-01 – 2001-12-31: -310280 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOVISTA INNOVATIVE THERAPIES, INC · 2001-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Operating Cash Flow: -310280 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -310280 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001259988-04-000042.txt#981 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 706,054 Exact value Exact value: -706054 USD 2002-01-01 – 2002-12-31: -706054 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOVISTA INNOVATIVE THERAPIES, INC · 2002-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Net Income: -706054 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -706054 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001019687-06-000076.txt#892 The citation records this snapshot. The page link may show a newer release later.	−USD 133,621 Exact value Exact value: -133621 USD 2002-01-01 – 2002-12-31: -133621 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOVISTA INNOVATIVE THERAPIES, INC · 2002-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Operating Cash Flow: -133621 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -133621 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001019687-06-000076.txt#907 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 387,429 Exact value Exact value: -387429 USD 2003-01-01 – 2003-12-31: -387429 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOVISTA INNOVATIVE THERAPIES, INC · 2003-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Net Income: -387429 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -387429 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001333072-06-000038.txt#3804 The citation records this snapshot. The page link may show a newer release later.	−USD 179,257 Exact value Exact value: -179257 USD 2003-01-01 – 2003-12-31: -179257 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOVISTA INNOVATIVE THERAPIES, INC · 2003-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Operating Cash Flow: -179257 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -179257 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001333072-06-000038.txt#4112 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 443,599 Exact value Exact value: -443599 USD 2004-01-01 – 2004-12-31: -443599 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOVISTA INNOVATIVE THERAPIES, INC · 2004-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Net Income: -443599 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -443599 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001333072-06-000038.txt#3804 The citation records this snapshot. The page link may show a newer release later.	−USD 164,050 Exact value Exact value: -164050 USD 2004-01-01 – 2004-12-31: -164050 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOVISTA INNOVATIVE THERAPIES, INC · 2004-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Operating Cash Flow: -164050 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -164050 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001333072-06-000038.txt#4112 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 273,674 Exact value Exact value: -273674 USD 2005-01-01 – 2005-12-31: -273674 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOVISTA INNOVATIVE THERAPIES, INC · 2005-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Net Income: -273674 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -273674 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-07-055580.txt#5023 The citation records this snapshot. The page link may show a newer release later.	−USD 116,714 Exact value Exact value: -116714 USD 2005-01-01 – 2005-12-31: -116714 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOVISTA INNOVATIVE THERAPIES, INC · 2005-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Operating Cash Flow: -116714 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -116714 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-07-055580.txt#5355 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2005-01-01 – 2005-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONCOVISTA INNOVATIVE THERAPIES, INC · 2005-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-07-055580.txt#5438 The citation records this snapshot. The page link may show a newer release later.	−USD 116,714 Calculation and evidence -116714 − 0 USD Exact free cash flow: -116714 USD 2005-01-01 – 2005-12-31: -116714 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONCOVISTA INNOVATIVE THERAPIES, INC · 2005-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Free cash flow: -116714 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -116714 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-07-055580.txt#5355 Input fundies:CapitalExpenditure: 0 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-07-055580.txt#5438 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 8.67 million Exact value Exact value: -8668222 USD 2006-01-01 – 2006-12-31: -8668222 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOVISTA INNOVATIVE THERAPIES, INC · 2006-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Net Income: -8668222 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8668222 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-08-022193.txt#17253 The citation records this snapshot. The page link may show a newer release later.	−USD 245,493 Exact value Exact value: -245493 USD 2006-01-01 – 2006-12-31: -245493 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOVISTA INNOVATIVE THERAPIES, INC · 2006-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Operating Cash Flow: -245493 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -245493 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-07-055580.txt#5355 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2006-01-01 – 2006-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ONCOVISTA INNOVATIVE THERAPIES, INC · 2006-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-07-055580.txt#5438 The citation records this snapshot. The page link may show a newer release later.	−USD 245,493 Calculation and evidence -245493 − 0 USD Exact free cash flow: -245493 USD 2006-01-01 – 2006-12-31: -245493 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ONCOVISTA INNOVATIVE THERAPIES, INC · 2006-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Free cash flow: -245493 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -245493 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-07-055580.txt#5355 Input fundies:CapitalExpenditure: 0 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-07-055580.txt#5438 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 5.6 million Exact value Exact value: -5602393 USD 2007-01-01 – 2007-12-31: -5602393 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOVISTA INNOVATIVE THERAPIES, INC · 2007-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Net Income: -5602393 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5602393 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-09-016837.txt#14555 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 7.48 million Exact value Exact value: -7482024 USD 2008-01-01 – 2008-12-31: -7482024 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOVISTA INNOVATIVE THERAPIES, INC · 2008-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Net Income: -7482024 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7482024 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-10-017663.txt#12167 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 4.78 million Exact value Exact value: -4783000 USD 2009-01-01 – 2009-12-31: -4783000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOVISTA INNOVATIVE THERAPIES, INC · 2009-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Net Income: -4783000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4783000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-11-018509.txt#8066 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	USD 10.1 million Exact value Exact value: 10103400 USD 2010-01-01 – 2010-12-31: 10103400 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOVISTA INNOVATIVE THERAPIES, INC · 2010-12-31 ONCOVISTA INNOVATIVE THERAPIES, INC (edgar:1094847) Net Income: 10103400 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1094847/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 10103400 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1094847/0001144204-11-018509.txt#8066 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

74 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001094847, 1094847, edgar:1094847

Also known as AVIATION UPGRADE TECHNOLOGIES INC

ONCOVISTA INNOVATIVE THERAPIES, INC

Latest quarter

Revenue

Trailing twelve months

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation